Articles
A research team from the University of Alabama at Birmingham have identified a gene in mice that can lead to skin wrinkles, gray hair, and hair loss….or the reversal of such disorders. Keshav Singh PhD and colleagues have discovered a genetic mutation affecting mitochondria to be a major regulator of health and the aging process.…
Read More
More news of progress is coming from Histogen and it’s going to raise a few eyebrows. This time, founder Gail Naughton gives details about the HSC660 trial in women and a late stage trial for men in Mexico. While browsing an article featuring Histogen on the San Diego Union Tribune website, I discovered some new…
Read MoreThings are heating up. Cassiopea SpA issued a press release today announcing “very positive” interim analysis phase 2 results for Breezula in the treatment of androgenic alopecia. Breezula is a topical anti-androgen and also known as Clascoterone. Here are some significant details I found while reading the release: The trial comprises 404 subjects and is…
Read More
Follicle Thought has received a brief update to share regarding the progress of the highly anticipated company Shiseido. On July 4th I sent a tweet to Replicel CEO Lee Buckler asking him when he thought we would hear an announcement from Shiseido pertaining to their trial of RCH-01. His response is shown below. As you…
Read More
I just received an email from Histogen that they have begun recruitment for their clinical trial of HSC660 in female pattern baldness. Full press release below. I know so many women are going to be happy reading this. 🙂 Histogen Press Release Histogen Kicks Off Clinical Trial for Female Hair Loss SAN DIEGO, July 2,…
Read More
I’m pleased to share with you all a startup which is a little bit “outside the box” from the usual companies you’d see on Follicle Thought. Today’s topic of interest, Birch BioMed, is based in Vancouver, Canada and was birthed on the campus of the University of British Columbia. The company’s prize clinical candidate is…
Read More
SCM Lifescience is a biotechnology company based in South Korea with a focus on adult stem cell therapeutics. The company had caught my eye several months ago when I read about its plans to develop a stem-cell derived product for hair growth. Since then, SCM seems to be making progress on that path. SCM Lifescience…
Read MoreThe New Yorker Magazine published an article this morning on the truly “age old quest” of curing hair loss. The article, written by Amos Barshad, is not your typical mainstream media wrap on baldness and its treatment horizon. Amos spoke to a large pool of the hair growth industry companies and household names. Featured in…
Read MoreToday, Follicum announced their phase 2a trial of FOL-005 for the scalp is fully recruited. The trial consists of injections of Follicum’s modified peptide, FOL-005, over a three month period. This trial design is supportive for a data readout by year’s end, as enrollment has been completed while still in June. CEO of Follicum, Jan…
Read More
Today, I am pleased to be sharing news of a stem-cell derived hair growth cosmetic product which could be available to consumers by the end of this year. While researching in the Follicle Thought lab recently 😉 I discovered the company Medipost, which is based in South Korea. Medipost is a biotechnology company that is…
Read More